反応式
[F:1][C:2]1[CH:7]=[CH:6][C:5]([NH2:8])=[CH:4][CH:3]=1.C1N=CN([C:14](N2C=NC=C2)=[O:15])C=1.[CH2:21]([O:23][C:24](=[O:43])[CH2:25][CH2:26][C:27]1[CH:32]=[CH:31][CH:30]=[C:29]([N:33]2[C:37]([NH2:38])=[CH:36][C:35]([C:39]([CH3:42])([CH3:41])[CH3:40])=[N:34]2)[CH:28]=1)[CH3:22].O>CN(C=O)C>[CH2:21]([O:23][C:24](=[O:43])[CH2:25][CH2:26][C:27]1[CH:32]=[CH:31][CH:30]=[C:29]([N:33]2[C:37]([NH:38][C:14]([NH:8][C:5]3[CH:6]=[CH:7][C:2]([F:1])=[CH:3][CH:4]=3)=[O:15])=[CH:36][C:35]([C:39]([CH3:42])([CH3:41])[CH3:40])=[N:34]2)[CH:28]=1)[CH3:22]参加物
反応物 4
生成物 1
試薬・触媒・溶媒 1
実験手順
A solution of 4-fluoro-phenylamine (111 mg, 1.0 mmol) and CDI (165 mg, 1.0 mmol) in DMF (2 mL) was stirred at RT for 30 min, and was then added to a solution of Example Z (315 mg, 1.0 mmol) in DMF (2 mL). The resulting mixture was stirred at RT overnight then added to water (50 mL). The reaction mixture was extracted with ethyl acetate (3×50 mL) and the combined organic extracts were washed with brine, dried (NaSO4) and filtered. After concentrated under reduced pressure, the residue was purified by flash chromatography to afford 3-(3-{3-t-butyl-5-[3-(4-fluoro-phenyl)-ureido]-pyrazol-1-yl}-phenyl)-propionic acid ethyl ester (150 mg, 33%). 1H-NMR (CDCl3): 7.91 (s, 1H), 7.42 (d, J=4.8 Hz, 1H), 7.37-7.34 (m, 2H), 7.28 (s, 1H), 7.17-7.16 (m, 2H), 6.98 (t, J=8.8 Hz, 2H), 6.59 (s, 1H), 4.04 (q, J=7.2 Hz, 2H), 3.03 (t, J=7.2 Hz, 2H), 2.77 (t, J=7.2 Hz, 2H), 1.36 (s, 9H), 1.17 (t, J=7.2 Hz, 3H); MS (ESI) m/z: 453 (M+H+).
後処理
- extractionThe reaction mixture was extracted with ethyl acetate (3×50 mL)
- washthe combined organic extracts were washed with brine
- dry with materialdried (NaSO4)
- filtrationfiltered
- concentrationAfter concentrated under reduced pressure
- customthe residue was purified by flash chromatography
出典と根拠
- ORDレコード
- ord-ba5911e4bc59464b9a2faab7173a5a1f
- 出典データセット
- uspto-grants-2009_05
- 特許番号
- US07531566B2
関連ノート
読み込み中…